Articles by Disease (Parkinsonian Disorders)

SIRT1 Promotes Neuronal Fortification in Neurodegenerative Diseases through Attenuation of Pathological Hallmarks and Enhancement of Cellular Lifespan

Journal: Current Neuropharmacology
Volume: 19
Page: 1019-1037
Author(s): Priya Mishra, Amit Kumar Mittal, Harikesh Kalonia, Swati Madan, Shampa Ghosh, Jitendra Kumar Sinha* and Satyendra Kumar Rajput*

Nanotechnology Driven Approaches for the Management of Parkinson’s Disease: Current Status and Future Perspectives

Journal: Current Drug Metabolism
Volume: 22
Page: 287-298
Author(s): Shrestha Sharma, Syed A. Rabbani*, Tanya Agarwal, Sanjula Baboota, Faheem H. Pottoo and Renu Kadian

Nanomedicine against Alzheimer’s and Parkinson’s Disease

Journal: Current Pharmaceutical Design
Volume: 27
Page: 1507-1545
Author(s): Ankit Tandon, Sangh J. Singh and Rajnish K. Chaturvedi*

Neurotoxic Mechanism and Shortcomings of MPTP, 6-OHDA, Rotenone and Paraquat-induced Parkinson’s Disease Animal Models

Journal: Venoms and Toxins
Volume: 1
Page: 27-40
Author(s): Samuel Kumi Okyere, Chaorong Zeng, Dong Yue and Yanchun Hu*

An Investigation of the Anti-Parkinsonism Potential of Co-enzyme Q₁₀ and Co-enzyme Q₁₀ /Levodopa-carbidopa Combination in Mice

Journal: Current Aging Science
Volume: 14
Page: 62-75
Author(s): Olakunle J. Onaolapo, Ademola O. Odeniyi, Stephen O. Jonathan, Moyinoluwa O. Samuel, Deborah Amadiegwu, Ajoke Olawale, Aisha O. Tiamiyu, Folusho O. Ojo, Hameed A. Yahaya, Oluwadamilare J. Ayeni and Adejoke Y. Onaolapo*

Tetrahydrobioterin (BH4) Pathway: From Metabolism to Neuropsychiatry

Journal: Current Neuropharmacology
Volume: 19
Page: 591-609
Author(s): H. Fanet, L. Capuron, N. Castanon, F. Calon and S. Vancassel*

Herbal Resources to Combat a Progressive & Degenerative Nervous System Disorder- Parkinson’s Disease

Journal: Current Drug Targets
Volume: 22
Page: 609-630
Author(s): Rajeev K. Singla, Tanya Agarwal, Xuefei He and Bairong Shen*

Current Quest in Natural Bioactive Compounds for Alzheimer’s Disease: Multi-Targeted-Designed-Ligand Based Approach with Preclinical and Clinical Based Evidence

Journal: Current Drug Targets
Volume: 22
Page: 685-720
Author(s): Ashif Iqubal, Syed Obaidur Rahman, Musheer Ahmed, Pratichi Bansal, Md Rafi Haider, Mohammad Kashif Iqubal, Abul Kalam Najmi, Faheem Hyder Pottoo and Syed Ehtaishamul Haque*

Implications of VIP and PACAP in Parkinson’s Disease: What do we Know So Far?

Journal: Current Medicinal Chemistry
Volume: 28
Page: 1703-1715
Author(s): Filipe Resende Oliveira de Souza, Fabiola Mara Ribeiro* and Patrícia Maria d’Almeida Lima*

123I-FP-CIT Brain SPECT Findings in Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency

Journal: Current Radiopharmaceuticals
Volume: 14
Page: 78-83
Author(s): Viviana Frantellizzi*, Mariano Pontico , Arianna Pani , Maria Silvia De Feo and Giuseppe De Vincentis